Topical terbinafine meets primary endpoint in Phase 3 study of onychomycosis patients

RCT (n=452) demonstrated non-inferiority of topical terbinafine vs. topical ciclopirox; treatment success (mycological cure and almost or completely clear great toenail) was reached for 21.9% of terbinafine patients vs. 18.9% in the ciclopirox group at 52 weeks.


Biospace Inc.